19:35 , Dec 5, 2017 |  BC Innovations  |  Distillery Therapeutics

Neurology

INDICATION: Spinal cord injury (SCI) Mouse studies suggest MaR1 could help treat acute spinal cord injury (SCI). In a mouse model of SCI, daily IV injection of MaR1 for seven days increased locomotor recovery, myelin content...
08:00 , Dec 4, 2014 |  BC Innovations  |  Distillery Therapeutics

Indication: Pulmonary disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Pulmonary disease Acute lung injury Maresin 1 (MaR1) In vitro and mouse studies suggest MaR1 could help protect...